CRI Ltd   Report issue

For profit Phase 3
Founded: Kolkata India (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2009
NCT01000792
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

CRI-Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

levocetirizine (xyzal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1